J&amp;J in US$25b Guidant buy
336179
LONDON: Johnson &amp; Johnson has agreed to acquire Guidant Corp for US$25.4bil, adding electrical devices for treating heart disease to a line-up of thousands of health products ranging from Band-Aids to cardiac stents.
718989
Johnson & Johnson aims to seal a  purchase of Guidant Corp. without immediately jettisoning the  medical device maker's stent operations, sources familiar with  the situation said on Thursday.
462708
Health care and consumer products maker Johnson &amp; Johnson is close to finalizing its long-rumored $24 billion cash and stock acquisition of medical-device maker Guidant Corp.
329296
Stocks stalled at the open Tuesday as investors shrugged off the impact of weaker crude prices and reports that Johnson &amp; Johnson is seeking to buy Guidant in a $24 billion deal.
253167
Johnson &amp; Johnson is in advanced talks to buy Guidant Corp. for more than $24 billion, the New York Times reported, citing executives whom the newspaper didn&#39;t name.
584724
Johnson &amp; Johnson (JNJ), the drug and health care products company, is reportedly in advanced negotiations to buy Guidant (GDT), a leading maker of devices to treat heart and circulatory illnesses, for more than $24 billion.
312138
U.S. stocks were little changed on  Tuesday, with lower oil prices helping support markets, but  Johnson & Johnson JNJ.N dragged on the Dow following a report  of a possible $24 billion takeover of cardiovascular device  maker Guidant Corp. GDT.N.
201236
Health care and consumer products maker Johnson &amp; Johnson (JNJ.N: Quote, Profile, Research) is in negotiations to acquire medical-device maker Guidant Corp.
430700
INDIANAPOLIS -- Johnson &amp; Johnson has sealed a deal to buy medical device maker Guidant for $25.4 billion. Under the terms of the agreement, each Guidant share will be exchanged for $30.40 in cash and $45.60 in Johnson &amp; Johnson stock.
134189
Johnson & Johnson  on Wednesday said it agreed to buy Guidant Corp. , for &#36;25.4 billion in cash and stock, giving the healthcare products maker a foothold in the fast-growing market for implantable devices that regulate heartbeats.
759956
Johnson & Johnson aims to seal a purchase of Guidant Corp. without immediately jettisoning the medical device maker's stent operations, sources familiar with the situation said on Thursday.
16804
Johnson &amp; Johnson Chief Executive Officer William Weldon plans to use the $25 billion purchase of defibrillator maker Guidant Corp.
202527
Johnson &amp; Johnson has made a deal to buy Guidant Corp. a producer of medical equipment for patients with heart and circulatory illnesses, for $24 billion in stock and cash.
169716
Johnson &amp; Johnson (JNJ:NYSE - news - research) said Wednesday night that it would acquire medical equipment maker Guidant (GDT:NYSE - news - research) for $23.9 billion in cash and stock.
595193
Johnson &amp; Johnson (JNJ:NYSE - news - research) reportedly is negotiating to buy Guidant (GDT:NYSE - news - research) for $24 billion, a transaction that would unite two big manufacturers of coronary devices.
760968
Johnson & Johnson  and a unit  of Pfizer Inc.  agreed to sell the U.S. rights to five  brands, including Balmex diaper rash treatment, to Chattem Inc.   for $410 million to satisfy regulatory requirements,  Chattem said on Friday.
72369
Johnson &amp; Johnson (J&amp;J) agreed yesterday to acquire Guidant Corporation for $25.4 billion (R147 billion), adding electrical devices for treating heart disease to